Skip to main content
Log in

Interleukin-1β-mediated suppression of microRNA-101 and upregulation of enhancer of zeste homolog 2 is involved in particle-induced lung cancer

Medical Oncology Aims and scope Submit manuscript

Abstract

Lung cancer may be a result of complex factors. Small mineral particle is the well-known inducer of lung cancer. Previous study revealed the high morbidity of lung cancer in Xuan Wei in China, and the main cause of lung cancer is the use of smoky coal there. And it is generally accepted that chronic inflammation induced by small mineral particle may be a cause of lung cancer. But the relationship between chronic lung inflammation and lung cancer is largely unknown. In the present study, we found that silica particle was able to induce the secretion of interleukin-1β from a Xuan Wei lung cancer cell line, XWLC-05. At the same time, microRNA-101 (mir-101) was found to be downregulated by the treatment of silica particle. Interestingly, the interleukin 1 receptor antagonist and interleukin-1β antibody can reduce silica particle-induced downregulation of mir-101. Twenty-four Xuan Wei lung tumor tissues were collected to detect the expression level of mir-101 and enhancer of zeste homolog 2 (EZH2), which is the potential target of mir-101. The results showed that mir-101 was down-regulated and EZH2 were upregulated. Subsequently, the roles of mir-101 and EZH2 in tumor growth and progression in vitro were tested. Overexpression of mir-101 mimics was able to suppress the expression of EZH2 in XWLC-05 cells. And this resulted in the inhibited tumor cell growth and attenuated cell migration. The results in the present study showed that particle can induce the secretion of interleukin-1β. Interleukin-1β subsequently induces the downregulation of mir-101, which may result in the upregulated level of EZH2, and occurrence of lung cancer. We for the first time proposed the role interleukin-1β–mir-101–EZH2 axes in the particle-induced lung cancer. Further study may be needed to decipher the detailed mechanism involved.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

References

  1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63:11–30.

    Article  PubMed  Google Scholar 

  2. Zhan P, Suo LJ, Qian Q, Shen XK, Qiu LX, et al. Chlamydia pneumoniae infection and lung cancer risk: a meta-analysis. Eur J Cancer. 2011;47:742–7.

    Article  PubMed  Google Scholar 

  3. Hecht SS. Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst. 1999;91:1194–210.

    Article  CAS  PubMed  Google Scholar 

  4. Forastiere F. Fine particles and lung cancer. Occup Environ Med. 2004;61:797–8.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  5. Mumford JL, He XZ, Chapman RS, Cao SR, Harris DB, et al. Lung cancer and indoor air pollution in Xuan Wei, China. Science. 1987;235:217–20.

    Article  CAS  PubMed  Google Scholar 

  6. Kim C, Chapman RS, Hu W, He X, Hosgood HD, et al. Smoky coal, tobacco smoking, and lung cancer risk in Xuanwei, China. Lung Cancer. 2014;84:31–5.

    Article  PubMed  Google Scholar 

  7. Saldiva PHN, Clarke RW, Coull BA, Stearns RC, Lawrence J, et al. Lung inflammation induced by concentrated ambient air particles is related to particle composition. Am J Respir Critic Care Med. 2002;165:1610–7.

    Article  Google Scholar 

  8. Hornung V, Bauernfeind F, Halle A, Samstad EO, Kono H, et al. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol. 2008;9:847–56.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  9. Kolb M, Margetts PJ, Anthony DC, Pitossi F, Gauldie J. Transient expression of IL-1beta induces acute lung injury and chronic repair leading to pulmonary fibrosis. J Clin Invest. 2001;107:1529–36.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  10. Tomankova T, Petrek M, Kriegova E (2010) Involvement of microRNAs in physiological and pathological processes in the lung. Respiratory Research 11.

  11. Chen K, Rajewsky N. The evolution of gene regulation by transcription factors and microRNAs. Nat Rev Genet. 2007;8:93–103.

    Article  CAS  PubMed  Google Scholar 

  12. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136:215–33.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  13. Cheng AM, Byrom MW, Shelton J, Ford LP. Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res. 2005;33:1290–7.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  14. Cao P, Deng ZY, Wan MM, Huang WW, Cramer SD, et al. MicroRNA-101 negatively regulates Ezh2 and its expression is modulated by androgen receptor and HIF-1 alpha/HIF-1 beta. Molecular Cancer 9 2010.

  15. Chen H, Rossier C, Antonarakis SE. Cloning of a human homolog of the Drosophila enhancer of zeste gene (EZH2) that maps to chromosome 21q22.2. Genomics. 1996;38:30–7.

    Article  CAS  PubMed  Google Scholar 

  16. Chang CJ, Hung MC. The role of EZH2 in tumour progression. Br J Cancer. 2012;106:243–7.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  17. Yang YA, Yu J. EZH2, an epigenetic driver of prostate cancer. Protein Cell. 2013;4:331–41.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  18. Kleer CG, Cao Q, Varambally S, Shen RL, Ota L, et al. EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. Proc Natl Acad Sci USA. 2003;100:11606–11.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  19. Hajosi-Kalcakosz S, Dezso K, Bugyik E, Bodor C, Paku S, et al. Enhancer of zeste homologue 2 (EZH2) is a reliable immunohistochemical marker to differentiate malignant and benign hepatic tumors. Diagn Pathol. 2012;7:86.

    Article  PubMed Central  PubMed  Google Scholar 

  20. Cao W, Ribeiro RD, Liu DA, Saintigny P, Xia RH, et al. EZH2 promotes malignant behaviors via cell cycle dysregulation and its mRNA level associates with prognosis of patient with non-small cell lung cancer. PLoS One 2012;7.

  21. Chang CJ, Hung MC. The role of EZH2 in tumour progression. Brit J Cancer. 2012;106:243–7.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  22. Kodach LL, Jacobs RJ, Heijmans J, van Noesel CJM, Langers AMJ, et al. The role of EZH2 and DNA methylation in the silencing of the tumour suppressor RUNX3 in colorectal cancer. Carcinogenesis. 2010;31:1567–75.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  23. Shin YJ, Kim JH The role of EZH2 in the regulation of the activity of matrix metalloproteinases in prostate cancer cells. PLoS One 2012;7.

  24. Jiang P, Yu GY, Zhang Y, Xiang Y, Hua HR, et al. Down-regulation of protease-activated receptor 4 in lung adenocarcinoma is associated with a more aggressive phenotype. Asian Pac J Cancer Prev. 2013;14:3793–8.

    Article  PubMed  Google Scholar 

  25. Xiang Y, Gao Q, Su W, Zeng L, Wang J, et al. Establishment, characterization and immortalization of a fibroblast cell line from the Chinese red belly toad Bombina maxima skin. Cytotechnology. 2012;64:95–105.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  26. Xiang Y, Wang X, Yan C, Gao Q, Li SA, et al. Adenosine-5′-triphosphate (ATP) protects mice against bacterial infection by activation of the NLRP3 inflammasome. PLoS ONE. 2013;8:e63759.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  27. Yan FC, Wang QQ, Ruan YH, Ma LJ, Jia JT, et al. Establishment and biological characteristics of lung cancer cell line XWLC-05. Ai Zheng. 2007;26:21–5.

    CAS  PubMed  Google Scholar 

  28. Huang F, Lin C, Shi YH, Kuerban G. MicroRNA-101 inhibits cell proliferation, invasion, and promotes apoptosis by regulating cyclooxygenase-2 in Hela cervical carcinoma cells. Asian Pac J Cancer Prev. 2013;14:5915–20.

    Article  PubMed  Google Scholar 

  29. Zhang Y, Yu G, Xiang Y, Wu J, Jiang P, et al. Bm-TFF2, a toad trefoil factor, promotes cell migration, survival and wound healing. Biochem Biophys Res Commun. 2010;398:559–64.

    Article  CAS  PubMed  Google Scholar 

  30. Cho HM, Jeon HS, Lee SY, Jeong KJ, Park SY, et al. microRNA-101 inhibits lung cancer invasion through the regulation of enhancer of zeste homolog 2. Exp Ther Med. 2011;2:963–7.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  31. Bachmann IM, Halvorsen OJ, Collett K, Stefansson IM, Straume O, et al. EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast. J Clin Oncol. 2006;24:268–73.

    Article  CAS  PubMed  Google Scholar 

  32. Pirker R. EGFR-directed monoclonal antibodies in non-small cell lung cancer. Target Oncol. 2013;8:47–53.

    Article  PubMed  Google Scholar 

  33. Rabinowits G, Gercel-Taylor C, Day JM, Taylor DD, Kloecker GH. Exosomal MicroRNA: a Diagnostic Marker for Lung Cancer. Clin Lung Cancer. 2009;10:42–6.

    Article  CAS  PubMed  Google Scholar 

  34. Borm PJA, Schins RPF, Albrecht C. Inhaled particles and lung cancer, part B: paradigms and risk assessment. Int J Cancer. 2004;110:3–14.

    Article  CAS  PubMed  Google Scholar 

  35. Voltolini L, Bongiolatti S, Luzzi L, Bargagli E, Fossi A, et al. Impact of interstitial lung disease on short-term and long-term survival of patients undergoing surgery for non-small-cell lung cancer: analysis of risk factors. Eur J Cardiothorac Surg. 2013;43:e17–23.

    Article  PubMed  Google Scholar 

  36. Wang L, Zhang LF, Wu J, Xu SJ, Xu YY, et al. IL-1beta-mediated repression of microRNA-101 is crucial for inflammation-promoted lung tumorigenesis. Cancer Res. 2014;74:4720–30.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by grants from the Wu Jieping Medical Foundation (320.6750.12708), Yunnan Department of Natural Science and Kunming Medical University Co-funding (Grant Nos. 2011FB227, 2011FB208, 2014FB175, 2014FB193).

Conflict of interest

The authors declare no conflict of interests.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Yang Xiang or Jian Dong.

Additional information

You-Ming Lei and Yun-Fen Zu have contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lei, YM., Zu, YF., Wang, J. et al. Interleukin-1β-mediated suppression of microRNA-101 and upregulation of enhancer of zeste homolog 2 is involved in particle-induced lung cancer. Med Oncol 32, 387 (2015). https://doi.org/10.1007/s12032-014-0387-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12032-014-0387-8

Keywords

Navigation